4/22
08:20 am
engn
enGene Holdings Inc. (NASDAQ: ENGN) is now covered by analysts at Wells Fargo & Company. They set an "overweight" rating and a $30.00 price target on the stock.
Low
Report
enGene Holdings Inc. (NASDAQ: ENGN) is now covered by analysts at Wells Fargo & Company. They set an "overweight" rating and a $30.00 price target on the stock.
4/15
08:11 am
engn
enGene Holdings Inc. (NASDAQ: ENGN) is now covered by analysts at Guggenheim. They set a "buy" rating and a $34.00 price target on the stock.
Low
Report
enGene Holdings Inc. (NASDAQ: ENGN) is now covered by analysts at Guggenheim. They set a "buy" rating and a $34.00 price target on the stock.
4/9
08:00 am
engn
engender Announces Hiring of Dr. Raja Ruth as Senior Vice President, Urologic Oncology and Clinical Development
Low
Report
engender Announces Hiring of Dr. Raja Ruth as Senior Vice President, Urologic Oncology and Clinical Development
3/28
09:07 am
engn
enGene Holdings Inc. (NASDAQ: ENGN) is now covered by analysts at UBS Group AG. They set a "buy" rating and a $37.00 price target on the stock.
Low
Report
enGene Holdings Inc. (NASDAQ: ENGN) is now covered by analysts at UBS Group AG. They set a "buy" rating and a $37.00 price target on the stock.
3/11
05:38 pm
engn
enGene Reports First Quarter 2024 Financial Results and Recent Corporate Progress [Yahoo! Finance]
Low
Report
enGene Reports First Quarter 2024 Financial Results and Recent Corporate Progress [Yahoo! Finance]
3/11
05:16 pm
engn
enGene Reports First Quarter 2024 Financial Results and Recent Corporate Progress
Low
Report
enGene Reports First Quarter 2024 Financial Results and Recent Corporate Progress
3/8
07:36 am
engn
enGene Holdings Inc. (NASDAQ: ENGN) is now covered by analysts at Morgan Stanley. They set an "overweight" rating and a $40.00 price target on the stock.
Low
Report
enGene Holdings Inc. (NASDAQ: ENGN) is now covered by analysts at Morgan Stanley. They set an "overweight" rating and a $40.00 price target on the stock.
3/5
07:00 am
engn
enGene To Present at the Leerink Partners Global Biopharma Conference
Low
Report
enGene To Present at the Leerink Partners Global Biopharma Conference
2/22
06:44 am
engn
enGene Holdings Inc. (NASDAQ: ENGN) had its "outperform" rating re-affirmed by analysts at Leerink Partnrs.
Medium
Report
enGene Holdings Inc. (NASDAQ: ENGN) had its "outperform" rating re-affirmed by analysts at Leerink Partnrs.
2/20
07:17 am
engn
enGene Holdings Inc. (NASDAQ: ENGN) is now covered by analysts at SVB Leerink LLC. They set an "outperform" rating and a $31.00 price target on the stock.
Medium
Report
enGene Holdings Inc. (NASDAQ: ENGN) is now covered by analysts at SVB Leerink LLC. They set an "outperform" rating and a $31.00 price target on the stock.
2/20
07:17 am
engn
enGene Holdings Inc. (NASDAQ: ENGN) is now covered by analysts at SVB Leerink LLC. They set an "outperform" rating and a $31.00 price target on the stock.
Medium
Report
enGene Holdings Inc. (NASDAQ: ENGN) is now covered by analysts at SVB Leerink LLC. They set an "outperform" rating and a $31.00 price target on the stock.
2/15
07:14 pm
engn
enGene Holdings: Mid-2024 NMIBC Data Could Lead To EG-70 BLA Filing [Seeking Alpha]
Medium
Report
enGene Holdings: Mid-2024 NMIBC Data Could Lead To EG-70 BLA Filing [Seeking Alpha]
2/14
02:58 pm
engn
Engene stock skyrockets as Montreal gene therapy developer raises $200-million on Nasdaq [Globe and Mail, The (Toronto, Canada)]
Medium
Report
Engene stock skyrockets as Montreal gene therapy developer raises $200-million on Nasdaq [Globe and Mail, The (Toronto, Canada)]
2/14
06:59 am
engn
enGene Announces Oversubscribed $200 Million Private Placement Financing [Yahoo! Finance]
High
Report
enGene Announces Oversubscribed $200 Million Private Placement Financing [Yahoo! Finance]
2/14
06:50 am
engn
enGene Announces Oversubscribed $200 Million Private Placement Financing
High
Report
enGene Announces Oversubscribed $200 Million Private Placement Financing
2/14
06:45 am
engn
enGene Announces Leadership Succession Plan
High
Report
enGene Announces Leadership Succession Plan
1/30
07:18 am
engn
enGene Appoints Lee Giguere as Chief Legal Officer and Corporate Secretary [Yahoo! Finance]
Low
Report
enGene Appoints Lee Giguere as Chief Legal Officer and Corporate Secretary [Yahoo! Finance]
1/30
07:00 am
engn
enGene Appoints Lee Giguere as Chief Legal Officer and Corporate Secretary
Low
Report
enGene Appoints Lee Giguere as Chief Legal Officer and Corporate Secretary
1/29
07:00 am
engn
enGene Reports Full Year 2023 Financial Results and Recent Operational Progress
High
Report
enGene Reports Full Year 2023 Financial Results and Recent Operational Progress